WuXi Biologics
Offering End-to-End Solutions
At WuXi XDC, we put customers first by providing high quality services and driving innovation to execute on your drug development needs and expedite your path to regulatory filing. Our research, development, and manufacturing capabilities along with our global footprint are continuously expanded to help you effectively and efficiently bring ADCs and bioconjugates to patients worldwide. Thus, to that end, and to keep you updated on our capabilities and technological advancements, we are pleased to provide you with periodic summaries that may be useful as you move through your product lifecycle.
Throughout all stages of your product development, WuXi XDC utilizes industry proven platforms to ensure cost-effective and robust execution of your project needs while also driving innovation to provide greater efficiency, lower the cost of goods and deliver safer, more efficacious, and higher quality bioconjugates. The following scientific posters, presented at various industry trade events and conferences, provide a snapshot of our various technology platforms and services to help you better reach your discovery, development, and clinical or commercial manufacturing goals.
WuXi Biologics Personnel:Nan Lu, Jiaqi Wu, Mengwei Tian, Shanshan Zhang, Zhiguo Li, Liming Shi
Journal:European Journal of Medicinal Chemistry
WuXi Biologics Personnel:Chunjiao Chen, Weiwei Jin, Jiawei Lu
Journal:Mol Pharm
WuXi Biologics Personnel:Shuai Shao, Mei-Hsuan Tsai, Jiawei Lu, Tao Yu, Jin Jin, Di Xiao, Huanhuan Jiang, Mo Han, Min Wang, Jun Wang
Journal:Bioorg Med Chem Lett
WuXi Biologics Personnel:Chunjiao Chen, Jiawei Lu
Journal:Chemistry
WuXi Biologics Personnel:Wenwen Cai, Chunjiao Chen, Hongxiang Zhou, Jiawei Lu
Journal:Bioconjug Chem
WuXi Biologics Personnel:Wenwen Cai, Hongxiang Zhou, Jiawei Lu
Journal:ACS Med Chem Lett
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?